Co ‐targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor‐resistant melanoma

EMBO Molecular Medicine, EarlyView.

Source: EMBO Molecular Medicine - April 11, 2018 Category: Molecular Biology Authors: Ileabett M Echevarr ía‐Vargas , Patricia I Reyes‐Uribe , Adam N Guterres , Xiangfan Yin , Andrew V Kossenkov , Qin Liu , Gao Zhang , Clemens Krepler , Chaoran Cheng , Zhi Wei , Rajasekharan Somasundaram , Giorgos Karakousis , Source Type: research